Merck KGaA 3Q Net Profit Fell; Lifts 2018 Organic Sales Growth View -- Update
November 14 2018 - 2:16AM
Dow Jones News
(Adds CEO quote, details on currency effects and outlook,
context for net profit decline.)
By Anthony Shevlin
Merck KGaA (MRK.XE) said Wednesday that third-quarter net profit
fell, but it raised its full-year organic sales growth expectations
on the performance of its Healthcare and Life Science businesses in
the quarter.
The German chemical and pharmaceuticals company reported net
profit for the quarter of 340 million euros ($382.7 million)
compared with EUR644 million a year earlier. The company said the
decline was due to a one-off gain of EUR321 million from its
divestment of the Biosimilars business reported the previous
year.
Earnings before interest, taxes, depreciation and amortization
was EUR919 million.
The company said sales for the quarter were EUR3.75 billion, up
6.6%. On an organic basis, sales rose 8.8%, the company said.
The negative foreign-exchange hit for the period was mainly
attributable to the worse-then-expected deterioration of the
Argentine peso and Brazilian real, said Merck.
Merck's Healthcare business delivered organic sales growth of
9.9% in the quarter while its Life Science business grew 9.8%.
"2018 was a challenging year for Merck. We made future-oriented
decisions that will lead to profitable growth as of 2019," said
Stefan Oschmann, chief executive of Merck.
The company now expects full-year organic sales growth of
between 4% and 6% compared with previous expectations of between 3%
and 5%. Merck confirmed its organic Ebitda pre-items forecast for
the year but says negative currency effects will hit its Ebitda
pre-items.
"The changed estimation of foreign-exchange effects is due to
the continued strong decline in value of Latin American currencies
against the euro," the company said.
Taking into account the treatment of the Consumer Health
business as a discontinued operation, Merck forecasts 2018 group
net sales between EUR14.4 billion and EUR14.8 billion.
Write to Anthony Shevlin at anthony.shevlin@dowjones.com;
@anthony_shevlin
(END) Dow Jones Newswires
November 14, 2018 02:01 ET (07:01 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.